New regional BioPharma Services’ dedicated solution enables seamless support for global cell and gene therapy clinical trials across multiple geographies for biopharmaceutical customers
Thermo Fisher Scientific Expands Global Footprint to Support Cell and Gene Therapy Clinical Trials in Japan (Photo: Business Wire)
TOKYO--(BUSINESS WIRE)--To help meet increasing demand for cell and gene therapy clinical trial support around the globe, Thermo Fisher Scientific, the world leader in serving science, today announced the expansion of its Fisher BioServices cryogenic service capabilities in Japan. This expansion enables its customers to seamlessly conduct clinical trials across multiple geographies and provides patients around the world with access to life changing therapies. As a leading service provider to the cell and gene therapy community, Fisher BioServices is uniquely positioned with the experience, resources, and global expertise to support its customers on their path towards commercialization.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161003005027/en/
Thermo Fisher Scientific
Marcia K. Goff, +1-508-902-7041